Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Clinical Neurology,Neurology
Reference54 articles.
1. Characterizing the mechanisms of progression in multiple sclerosis. Evidence and new hypotheses for future directions;Frohman;Arch Neurol,2005
2. Demyelination: the role of reactive oxygen and nitrogen species;Felts;Brain Pathol,1999
3. Electrically active axons degenerate when exposed to nitric oxide;Smith;Ann Neurol,2001
4. The window of therapeutic opportunity in multiple sclerosis. Evidence from monoclonal antibody therapy;Coles;J Neurol,2006
5. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult;Graumann;Brain Pathol,2003
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT;Efficacy and Mechanism Evaluation;2020-05
2. Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview;CNS Drugs;2018-06
3. Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study;Brain;2016-01-20
4. Sodium channel blockers for neuroprotection in multiple sclerosis;Cochrane Database of Systematic Reviews;2015-10-21
5. Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis;PLOS ONE;2015-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3